Business
DIAGNOS Opens First US Office in Florida
BROSSARD, Quebec, March 31, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the...
About this update from Diagnos Inc.
[{"type":"text","content":"DIAGNOS Opens First US Office in Florida\n\n\n\n BROSSARD, Quebec, March 31, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalmic health issues using advanced technology based on Artificial Intelligence (AI), is excited to announce the opening of a new office in Fort Lauderdale that will serve to meet potential clients and conduct demos to key stakeholders in the ophthalmic and optometry sectors in Florida.\n \n\n As part of its growth strategy, DIAGNOS has identified Florida to establish its first office in the United States due its pro-business climate, talented workforce, global connectivity, demographics and quality of life. “We are thrilled to have established an office in the USA and further extend our reach to new clients,” said André Larente, President and CEO of DIAGNOS. Mr. Larente added “our expansion into Florida aligns with our strategic vision of meeting our clients’ needs wherever they may be located.” DIAGNOS plans on hiring its first US employees in the state of Florida.\n \n\n On February 25, 2025, DIAGNOS announced that it is working on the US FDA certification related to major advances of its AI-assisted fundus image analysis platform that should be available later this year. The updated platform has been redesigned to assist healthcare professionals in the assisted analysis of fundus images as it relates to indicators used in the identification and stratification of diabetic retinopathy, hypertensive retinopathy, and age-related macular degeneration.\n \n\n DIAGNOS also announces the engagement of DS Market Solutions Inc. (“DSMS”) to maintain an orderly market in the Corporation’s tradeable securities.\n \n\n As per the agreement signed between DSMS and DIAGNOS, DSMS is entitled to a compensation of CA$5,000 per month, payable in advance in cash, starting April 1, 2025, renewable on a month-to-month basis. DIAGNOS may terminate the agreement upon a 30-day written notice. DIAGNOS will use its own liquidities to pay the monthly compensation of CA$5,000.\n \n\n Headquartered in Mississauga, in the province of Ontario, Canada, DSMS will provide market-making services with respect to the Corporation’s trade...